CEBPG: CCAAT Enhancer Binding Protein Gamma

A key transcriptional regulator in hematopoiesis, immune response, and cancer

Gene Information Card

Symbol CEBPG
Full Name CCAAT enhancer binding protein gamma
Gene Type protein-coding
Chromosomal Location 19q13.11
NCBI Gene ID 1054 ncbi.nlm.nih.gov/gene/1054
Ensembl ID ENSG00000105679
UniProt ID P53567
OMIM ID 116897
HGNC ID 2426
Aliases GPE1BP, C/EBP-gamma, CEBPG1

Description

CEBPG encodes a member of the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors. The protein forms heterodimers with other C/EBP family members (e.g., CEBPA, CEBPB) and regulates genes involved in immune and inflammatory responses, hematopoiesis, and cell differentiation. CEBPG is widely expressed and plays a role in myeloid and lymphoid development, as well as in cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Acute Myeloid Leukemia CEBPG mutations may disrupt normal myeloid differentiation by altering C/EBP heterodimer formation COSMIC, ClinVar
Chronic Lymphocytic Leukemia CEBPG overexpression or mutation contributes to B-cell survival and proliferation COSMIC
Breast Cancer CEBPG dysregulation influences epithelial-mesenchymal transition and metastasis NCBI Gene, COSMIC
Inflammatory Bowel Disease CEBPG regulates cytokine expression in intestinal inflammation OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Bone Marrow 15.2 High
Lymph Node 12.8 High
Spleen 11.5 High
Lung 8.3 Medium
Liver 6.1 Medium
Brain 2.4 Low
Cell Line Expression
Cell Line nTPM Notes
K562 (leukemia) 18.7 High expression; model for myeloid differentiation
HL-60 (promyeloblast) 16.3 High expression; role in granulopoiesis
MCF7 (breast cancer) 9.2 Moderate expression; associated with EMT
HEK293 (embryonic kidney) 5.1 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.437C>T (p.Pro146Leu) Missense 0.02% (COSMIC) May alter DNA-binding affinity
c.523_524insA (p.Thr175Asnfs*12) Frameshift 0.01% (COSMIC) Loss of function; truncated protein
c.689G>A (p.Arg230Gln) Missense 0.03% (ClinVar) Uncertain significance; reported in AML
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the bZIP domain impair DNA binding and heterodimerization, leading to loss of transcriptional activity.

Gain of Function (GOF)

Missense mutations in the transactivation domain may enhance CEBPG stability or interaction with coactivators, though evidence is limited.

Dominant Negative (DN)

Mutations that produce truncated proteins capable of dimerizing with wild-type C/EBP factors but unable to bind DNA can act in a dominant-negative manner.

Pathways

IL-6 signaling pathway (Reactome: R-HSA-1059683)
C/EBP transcription factor network (KEGG: hsa04630)
Myeloid cell differentiation (WikiPathways: WP2841)

Protein Summary

CEBPG is a 150-amino-acid transcription factor containing a basic leucine zipper (bZIP) domain. It lacks a transactivation domain and functions primarily as a heterodimeric partner for other C/EBP proteins. Through dimerization, it modulates the expression of genes involved in inflammation, hematopoiesis, and cell cycle control. Post-translational modifications such as phosphorylation regulate its activity and stability.

Related Products

Product name Cat.No. Species Gene ID
CEBPG Knockout HEK293 Cell Line EDJ-KQ3554 Human 1054 Details Get a Quote
CEBPG Knockout A-549 Cell Line EDJ-KQ26723 Human 1054 Details Get a Quote
CEBPG Knockout HCT 116 Cell Line EDJ-KQ26725 Human 1054 Details Get a Quote
CEBPG Knockout HeLa Cell Line EDJ-KQ26726 Human 1054 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: